7749.T JPX
Medikit Co.,Ltd.
1W: -1.1%
1M: -3.7%
3M: +0.1%
YTD: -8.4%
1Y: +10.5%
3Y: +20.0%
5Y: +1.9%
¥2,771.00 ($17.59)
-1.00 (-0.04%)
Weekly Expected Move ±2.0%
¥2660
¥2716
¥2772
¥2828
¥2884
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$3.6B
-26.3% ▼
5Y CAGR: +0.1%
Capital Expenditures
$3.8B
-123.7% ▼
5Y CAGR: +21.4%
Free Cash Flow
-$255M
-108.1% ▼
Dividends Paid
$1.3B
+24.1% ▲
Buybacks
$551M
+88.6% ▲
Net Change in Cash
-$2.1B
-235.2% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $2.7B | $3.0B | $2.9B | $3.1B | $3.0B |
| Depreciation & Amort. | $1.3B | $1.3B | $1.3B | $1.5B | $1.7B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $63M | -$1.6B | -$475M | -$29M | -$1.2B |
| Other Non-Cash Items | -$401M | $442M | $768M | $249M | $60M |
| Operating Cash Flow | $3.6B | $3.2B | $4.5B | $4.8B | $3.6B |
| — Investing Activities — | |||||
| Capital Expenditures | -$1.5B | -$1.8B | -$1.0B | -$1.7B | -$3.8B |
| Acquisitions (Net) | $0 | $38M | -$2.6B | -$632M | $1M |
| Investment Purchases | -$23.2B | -$23.0B | -$23.0B | -$17.5B | -$12.0B |
| Investment Sales | $23.1B | $23.0B | $23.0B | $23.1B | $12.0B |
| Other Investing | $12M | $32M | $11M | -$8M | -$17M |
| Investing Cash Flow | -$1.6B | -$1.7B | -$3.6B | $3.2B | -$3.9B |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | -$447M | -$67M | $0 | -$4.8B | -$551M |
| Dividends Paid | -$848M | -$835M | -$1.5B | -$1.8B | -$1.3B |
| Other Financing | $0 | -$1K | $0 | -$351K | $0 |
| Financing Cash Flow | -$1.3B | -$901M | -$1.5B | -$6.6B | -$1.9B |
| Net Change in Cash | $658M | $627M | -$525M | $1.5B | -$2.1B |
| Cash End of Period | $17.5B | $18.1B | $17.6B | $19.1B | $17.1B |
| Free Cash Flow | $2.1B | $1.4B | $3.5B | $3.1B | -$255M |